Aseptic spray drying offers a technology alternative to manufacture thermally stable vaccines.
Vaccine doses are often wasted due to challenges in maintaining cold storage from the manufacturing site to the patient. Aseptic spray drying offers a technology alternative to manufacture thermally stable vaccines, which can help ensure the stability and effectiveness of vaccines, extend shelf life, and reduce the potential for waste of these crucial products.
Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing May 2021 eBook.
Sam de Costa is stabilization projects manager, Nova Laboratories Limited.
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 18–24
When referring to this article, please cite it as S. de Costa, “Breaking the Cold Chain for Vaccines," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.